National Institute of Mental Health; Notice of Meeting, 38713-38714 [2018-16794]
Download as PDF
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices
Guy by email: guyr2@niehs.nih.gov by
August 29, 2018.
Meeting Materials: The preliminary
meeting agenda is available on the
meeting web page https://
ntp.niehs.nih.gov/go/32822 and will be
updated one week before the meeting.
Individuals are encouraged to access the
meeting web page to stay abreast of the
most current information regarding the
meeting.
Background Information on ICCVAM,
NICEATM, and SACATM: ICCVAM is
an interagency committee composed of
representatives from 16 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
with regulatory applicability and
promotes the scientific validation and
regulatory acceptance of toxicological
and safety-testing methods that more
accurately assess the safety and hazards
of chemicals and products and that
reduce, refine (decrease or eliminate
pain and distress), or replace animal
use. The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l–3) established
ICCVAM as a permanent interagency
committee of the NIEHS under
NICEATM.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,
and conducts independent validation
studies to assess the usefulness and
limitations of new, revised, and
alternative test methods and strategies.
NICEATM and ICCVAM work
collaboratively to evaluate new and
improved test methods and strategies
applicable to the needs of U.S. federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative test methods
and strategies for validation studies and
technical evaluations. Additional
information about ICCVAM and
NICEATM can be found at https://
ntp.niehs.nih.gov/go/iccvam and https://
ntp.niehs.nih.gov/go/niceatm.
SACATM was established in response
to the ICCVAM Authorization Act
[Section 285l–3(d)] and is composed of
scientists from the public and private
sectors. SACATM advises ICCVAM,
NICEATM, and the Director of the
NIEHS and NTP regarding statutorily
mandated duties of ICCVAM and
activities of NICEATM. SACATM
provides advice on priorities and
activities related to the development,
validation, scientific review, regulatory
acceptance, implementation, and
national and international
VerDate Sep<11>2014
16:54 Aug 06, 2018
Jkt 244001
harmonization of new, revised, and
alternative toxicological test methods.
Additional information about
SACATM, including the charter, roster,
and records of past meetings, can be
found at https://ntp.niehs.nih.gov/go/
167.
Dated: July 24, 2018.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2018–16840 Filed 8–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Interagency Autism
Coordinating Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of Meeting: Open Meeting.
Date: Wednesday, October 17, 2018.
Time: 9:00 a.m. to 5:00 p.m. *Eastern
Time* Approximate end time.
Agenda: To discuss business, updates, and
issues related to ASD research and services
activities.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C and D,
Rockville, MD 20852.
Webcast Live: https://videocast.nih.gov.
Conference Call Access: Dial: 800–369–
3190.
Access Code: 1724926.
Cost: The meeting is free and open to the
public.
Registration: A registration web link will
be posted on the IACC website
(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended to expedite
check-in. Seating in the meeting room is
limited to room capacity and on a first come,
first served basis. Onsite registration will also
be available.
Deadlines: Notification of interest to
present oral comments: Friday, October 5,
2018 by 5:00 p.m. ET
Submission of written/electronic statement
for oral comments: Tuesday, October 9, 2018
by 5:00 p.m. ET
Submission of written comments: Tuesday,
October 9, 2018 by 5:00 p.m. ET
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
38713
For IACC Public Comment guidelines
please see: https://iacc.hhs.gov/meetings/
public-comments/guidelines/
Access: White Flint Metro Station (Red
Line) in combination with a brief walk.
Contact Person: Ms. Angelice Mitrakas,
Office of Autism Research Coordination,
National Institute of Mental Health, NIH,
6001 Executive Boulevard, Room 6182A,
Bethesda, MD 20892–9669, Phone: 301–435–
9269, Email: IACCPublicInquiries@
mail.nih.gov.
Public Comments: Any member of the
public interested in presenting oral
comments to the IACC must notify the
Contact Person listed on this notice by
5:00 p.m. ET on Friday, October 5, 2018
with their request to present oral
comments at the meeting, and a written/
electronic copy of the oral presentation/
statement must be submitted by 5:00
p.m. ET on Tuesday, October 9, 2018. A
limited number of slots for oral
comment are available, and in order to
ensure that as many different
individuals are able to present
throughout the year as possible, any
given individual only will be permitted
to present oral comments once per
calendar year (2018). Only one
representative of an organization will be
allowed to present oral comments in
any given meeting; other representatives
of the same group may provide written
comments. If the oral comment session
is full, individuals who could not be
accommodated are welcome to provide
written comments instead. Comments to
be read or presented in the meeting will
be assigned a 3–5 minute time slot
depending on the number of comments,
but a longer version may be submitted
in writing for the record. Commenters
going beyond their allotted time in the
meeting may be asked to conclude
immediately in order to allow other
comments and presentations to proceed
on schedule.
Any interested person may submit
written public comments to the IACC
prior to the meeting by emailing the
comments to IACCPublicInquiries@
mail.nih.gov or by submitting comments
at the web link: https://iacc.hhs.gov/
meetings/public-comments/submit/
index.jsp by 5:00 p.m. ET on Tuesday,
October 9, 2018. The comments should
include the name, address, telephone
number, and when applicable, the
business or professional affiliation of
the interested person. National Institute
on Mental Health (NIMH) anticipates
written public comments received by
5:00 p.m. ET on Tuesday, October 9,
2018 will be presented to the IACC prior
to the meeting for the IACC’s
consideration. Any written comments
received after the 5:00 p.m. ET, October
9, 2018 deadline through October 15,
E:\FR\FM\07AUN1.SGM
07AUN1
daltland on DSKBBV9HB2PROD with NOTICES
38714
Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices
2018 will be provided to the IACC either
before or after the meeting, depending
on the volume of comments received
and the time required to process them
in accordance with privacy regulations
and other applicable Federal policies.
All written public comments and oral
public comment statements received by
the deadlines for both oral and written
public comments will be provided to
the IACC for their consideration and
will become part of the public record.
Attachments of copyrighted
publications are not permitted, but web
links or citations for any copyrighted
works cited may be provided.
In the 2016–2017 IACC Strategic Plan,
the IACC listed the ‘‘Spirit of
Collaboration’’ as one of its core values,
stating that, ‘‘We will treat others with
respect, listen with open minds to the
diverse views of people on the autism
spectrum and their families,
thoughtfully consider community input,
and foster discussions where
participants can comfortably where
participants can comfortably offer
opposing opinions.’’ In keeping with
this core value, the IACC and the NIMH
Office of Autism Research Coordination
ask that members of the public who
provide public comments or participate
in meetings of the IACC also seek to
treat others with respect and
consideration in their communications
and actions, even when discussing
issues of genuine concern or
disagreement.
Remote Access: The meeting will be
open to the public through a conference
call phone number and webcast live on
the internet. Members of the public who
participate using the conference call
phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with
the webcast or conference call, please
send an e- mail to IACCPublicInquiries@
mail.nih.gov or call 240–668–0302.
Individuals wishing to participate in
person or by using these electronic
services and who need special
assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a
request to the Contact Person listed on
this notice at least five days prior to the
meeting.
Security: Visitors will be asked to
show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state
the purpose of their visit. Also, as a part
of security procedures, attendees should
be prepared to present a photo ID at the
meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited
to the room capacity and seats will be
VerDate Sep<11>2014
16:54 Aug 06, 2018
Jkt 244001
on a first come, first served basis, with
expedited check-in for those who are
pre-registered.
Meeting schedule subject to change.
Information about the IACC is available
on the website: https://www.iacc.hhs.gov.
Dated: August 1, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–16794 Filed 8–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
meeting of the Council of Councils.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://videocast.
nih.gov).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4), and 552b(c)(6), Title 5
U.S.C., as amended. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Council of Councils.
Open: September 7, 2018.
Time: 8:15 a.m. to 12:15 p.m.
Agenda: Call to Order and Introductions;
Announcements and Updates; Environmental
influences on Child Health Outcomes
(ECHO), Program Genetics and Epigenetics
Research to be Supported by Future ECHO
Genetics Core; All of Us Research Program
Update; NIH Update; Common Fund
Program—Stimulating Peripheral Activity to
Address Conditions.
Place: National Institutes of Health, 9000
Rockville Pike, Building 60/Cloisters, Lecture
Hall/Chapel, Bethesda, MD 20892.
Closed: September 7, 2018.
Time: 12:25 p.m. to 1:25 p.m.
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Agenda: Review of Grant Applications.
Place: National Institutes of Health, 9000
Rockville Pike, Building 60/Cloisters, Lecture
Hall/Chapel, Bethesda, MD 20892.
Open: September 7, 2018.
Time: 1:25 p.m. to 4:30 p.m.
Agenda: Council Operating Procedures;
Workshop Report on Contributions of Social
and Behavioral Research in Addressing the
Opioid Crisis; Retiring Council Members’
Perspectives.
Place: National Institutes of Health, 9000
Rockville Pike, Building 60/Cloisters, Lecture
Hall/Chapel, Bethesda, MD 20892.
Contact Person: Franziska Grieder, D.V.M.,
Ph.D., Executive Secretary, Council of
Councils Director, Office of Research
Infrastructure Programs, Division of Program
Coordination, Planning, and Strategic
Initiatives, Office of the Director, NIH, 6701
Democracy Boulevard, Room 948, Bethesda,
MD 20892, GriederF@mail.nih.gov, 301–435–
0744.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Council of Council’s home page at https://
dpcpsi.nih.gov/council/ where an agenda
will be posted before the meeting date.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: August 1, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–16792 Filed 8–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\07AUN1.SGM
07AUN1
Agencies
[Federal Register Volume 83, Number 152 (Tuesday, August 7, 2018)]
[Notices]
[Pages 38713-38714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16794]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Interagency Autism
Coordinating Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Interagency Autism Coordinating Committee
(IACC).
Type of Meeting: Open Meeting.
Date: Wednesday, October 17, 2018.
Time: 9:00 a.m. to 5:00 p.m. *Eastern Time* Approximate end
time.
Agenda: To discuss business, updates, and issues related to ASD
research and services activities.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Conference Room C and D, Rockville, MD 20852.
Webcast Live: https://videocast.nih.gov.
Conference Call Access: Dial: 800-369-3190.
Access Code: 1724926.
Cost: The meeting is free and open to the public.
Registration: A registration web link will be posted on the IACC
website (www.iacc.hhs.gov) prior to the meeting. Pre-registration is
recommended to expedite check-in. Seating in the meeting room is
limited to room capacity and on a first come, first served basis.
Onsite registration will also be available.
Deadlines: Notification of interest to present oral comments:
Friday, October 5, 2018 by 5:00 p.m. ET
Submission of written/electronic statement for oral comments:
Tuesday, October 9, 2018 by 5:00 p.m. ET
Submission of written comments: Tuesday, October 9, 2018 by 5:00
p.m. ET
For IACC Public Comment guidelines please see: https://iacc.hhs.gov/meetings/public-comments/guidelines/
Access: White Flint Metro Station (Red Line) in combination with
a brief walk.
Contact Person: Ms. Angelice Mitrakas, Office of Autism Research
Coordination, National Institute of Mental Health, NIH, 6001
Executive Boulevard, Room 6182A, Bethesda, MD 20892-9669, Phone:
301-435-9269, Email: [email protected].
Public Comments: Any member of the public interested in presenting
oral comments to the IACC must notify the Contact Person listed on this
notice by 5:00 p.m. ET on Friday, October 5, 2018 with their request to
present oral comments at the meeting, and a written/electronic copy of
the oral presentation/statement must be submitted by 5:00 p.m. ET on
Tuesday, October 9, 2018. A limited number of slots for oral comment
are available, and in order to ensure that as many different
individuals are able to present throughout the year as possible, any
given individual only will be permitted to present oral comments once
per calendar year (2018). Only one representative of an organization
will be allowed to present oral comments in any given meeting; other
representatives of the same group may provide written comments. If the
oral comment session is full, individuals who could not be accommodated
are welcome to provide written comments instead. Comments to be read or
presented in the meeting will be assigned a 3-5 minute time slot
depending on the number of comments, but a longer version may be
submitted in writing for the record. Commenters going beyond their
allotted time in the meeting may be asked to conclude immediately in
order to allow other comments and presentations to proceed on schedule.
Any interested person may submit written public comments to the
IACC prior to the meeting by emailing the comments to
[email protected] or by submitting comments at the web
link: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp by
5:00 p.m. ET on Tuesday, October 9, 2018. The comments should include
the name, address, telephone number, and when applicable, the business
or professional affiliation of the interested person. National
Institute on Mental Health (NIMH) anticipates written public comments
received by 5:00 p.m. ET on Tuesday, October 9, 2018 will be presented
to the IACC prior to the meeting for the IACC's consideration. Any
written comments received after the 5:00 p.m. ET, October 9, 2018
deadline through October 15,
[[Page 38714]]
2018 will be provided to the IACC either before or after the meeting,
depending on the volume of comments received and the time required to
process them in accordance with privacy regulations and other
applicable Federal policies. All written public comments and oral
public comment statements received by the deadlines for both oral and
written public comments will be provided to the IACC for their
consideration and will become part of the public record. Attachments of
copyrighted publications are not permitted, but web links or citations
for any copyrighted works cited may be provided.
In the 2016-2017 IACC Strategic Plan, the IACC listed the ``Spirit
of Collaboration'' as one of its core values, stating that, ``We will
treat others with respect, listen with open minds to the diverse views
of people on the autism spectrum and their families, thoughtfully
consider community input, and foster discussions where participants can
comfortably where participants can comfortably offer opposing
opinions.'' In keeping with this core value, the IACC and the NIMH
Office of Autism Research Coordination ask that members of the public
who provide public comments or participate in meetings of the IACC also
seek to treat others with respect and consideration in their
communications and actions, even when discussing issues of genuine
concern or disagreement.
Remote Access: The meeting will be open to the public through a
conference call phone number and webcast live on the internet. Members
of the public who participate using the conference call phone number
will be able to listen to the meeting but will not be heard. If you
experience any technical problems with the webcast or conference call,
please send an e- mail to [email protected] or call 240-
668-0302.
Individuals wishing to participate in person or by using these
electronic services and who need special assistance, such as captioning
of the conference call or other reasonable accommodations, should
submit a request to the Contact Person listed on this notice at least
five days prior to the meeting.
Security: Visitors will be asked to show one form of identification
(for example, a government-issued photo ID, driver's license, or
passport) and to state the purpose of their visit. Also, as a part of
security procedures, attendees should be prepared to present a photo ID
at the meeting registration desk during the check-in process. Pre-
registration is recommended. Seating will be limited to the room
capacity and seats will be on a first come, first served basis, with
expedited check-in for those who are pre-registered.
Meeting schedule subject to change. Information about the IACC is
available on the website: https://www.iacc.hhs.gov.
Dated: August 1, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16794 Filed 8-6-18; 8:45 am]
BILLING CODE 4140-01-P